Combined hypoxia inducible factor-1α and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits

Journal of Thoracic and Cardiovascular Surgery

Volumn 150, Issue 3, 2015, Pages 621-632

  Cao, Guangqing ^a   Liu, Chuanzhen ^a   Wan, Zhaojie ^a   Liu, Kai ^a   Sun, Hourong ^a   Sun, Xiangfei ^a   Tang, Mengmeng ^a   Bing, Weidong ^a   Wu, Shuming ^a   Pang, Xinyan ^a   Zhang, Xiquan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Congenital heart disease; endothelial progenitor cells; HIF 1 ; pulmonary arterial hypertension; rabbits

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN;

ANASTOMOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CATHETERIZATION; COMMON CAROTID ARTERY; ENDOTHELIAL PROGENITOR CELL; EXPERIMENTAL MODEL; HOMOGENEOUS ENDOTHELIAL PROGENITOR CELL THERAPY; HYPERTROPHY; JUGULAR VEIN; LENTIVIRINAE; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SHUNT FLOW INDUCED PULMONARY ARTERIAL HYPERTENSION; STEM CELL TRANSPLANTATION; VASCULAR REMODELING; ANGIOGENESIS; ANIMAL; ARTERIAL PRESSURE; BIOSYNTHESIS; CELL CULTURE; DISEASE MODEL; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION, PULMONARY; LUNG CIRCULATION; METABOLISM; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY ARTERY; RABBIT; TIME FACTOR; TRANSPLANTATION;

ANIMALS; ARTERIAL PRESSURE; CELLS, CULTURED; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ENDOTHELIAL PROGENITOR CELLS; GENETIC THERAPY; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY ARTERY; PULMONARY CIRCULATION; RABBITS; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSFECTION; VASCULAR REMODELING;

EID: 84940448367     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2015.05.035     Document Type: Article

References (41)

1. G. Pietra, W. Edwards, J. Kay, S. Rich, J. Kernis, B. Schloo, and et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, primary pulmonary hypertension registry Circulation 80 1989 1198 1206
2. S. Talwar, V.K. Keshri, S.K. Choudhary, S.K. Gupta, S. Ramakrishnan, A. Saxena, and et al. Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension: hemodynamic outcomes J Thorac Cardiovasc Surg 148 2014 2570 2575
3. J. Roos-Hesselink, F. Meijboom, S. Spitaels, R. Van Domburg, E. van Rijen, E. Utens, and et al. Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years Eur Heart J 25 2004 1057 1062
4. R.M. Tuder, C.D. Cool, M. Yeager, L. Taraseviciene-Stewart, T.M. Bull, and N.F. Voelkel The pathobiology of pulmonary hypertension: endothelium Clin Chest Med 22 2001 405 418
5. N.F. Voelkel, R.A. Quaife, L.A. Leinwand, R.J. Barst, M.D. McGoon, D.R. Meldrum, and et al. Right ventricular function and failure report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure Circulation 114 2006 1883 1891
6. M. Humbert, O. Sitbon, and G. Simonneau Treatment of pulmonary arterial hypertension N Engl J Med 351 2004 1425 1436
7. E.D. Michelakis, M.R. Wilkins, and M. Rabinovitch Emerging concepts and translational priorities in pulmonary arterial hypertension Circulation 118 2008 1486 1495
8. N. Galie, A. Manes, M. Palazzini, L. Negro, A. Marinelli, S. Gambetti, and et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome Drugs 68 2008 1049 1066
9. B. Cristofaro, O.A. Stone, A. Caporali, D. Dawbarn, N. Ieronimakis, M. Reyes, and et al. Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia Arterioscler Thromb Vasc Biol 30 2010 1143 1150
10. M. Oostendorp, K. Douma, A. Wagenaar, J.M. Slenter, T.M. Hackeng, M.A. van Zandvoort, and et al. Molecular magnetic resonance imaging of myocardial angiogenesis after acute myocardial infarction Circulation 121 2010 775 783
11. L. Jiang, X.H. Song, P. Liu, C.L. Zeng, Z.S. Huang, L.J. Zhu, and et al. Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension Cell Transplant 21 2012 1463 1475
12. K. Liu, R. Liu, G. Cao, H. Sun, X. Wang, and S. Wu Adipose-derived stromal cell autologous transplantation ameliorates pulmonary arterial hypertension induced by shunt flow in rat models Stem Cells Develop 20 2010 1001 1010
13. M. Toshner, and N.W. Morrell Endothelial progenitor cells in pulmonary hypertension - dawn of cell-based therapy? Int J Clin Pract Suppl 165 2010 7 12
14. H.K. Yip, L.T. Chang, C.K. Sun, J.J. Sheu, C.H. Chiang, A.A. Youssef, and et al. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats Crit Care Med 36 2008 873 880
15. E.H. Yao, N. Fukuda, T. Matsumoto, M. Katakawa, C. Yamamoto, Y. Han, and et al. Effects of the antioxidative β-blocker celiprolol on endothelial progenitor cells in hypertensive rats Am J Hyperten 21 2008 1062 1068
16. W. Wang, K. Liu, F. Zhang, G. Cao, Y. Zhang, R. Liu, and et al. Recombinant human hepatocyte growth factor transfection alleviates hyperkinetic pulmonary artery hypertension in rabbit models J Thorac Cardiovasc Surg 146 2013 198 205
17. F. Zhang, S. Wu, X. Lu, M. Wang, and M. Liu Gene transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits Ann Thorac Surg 85 2008 581 585
18. L. Farkas, D. Farkas, K. Ask, A. Moller, J. Gauldie, P. Margetts, and et al. Vegf ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats J Clin Invest 119 2009 1298 1311
19. I.B. Gubrij, S.R. Martin, A.K. Pangle, R.C. Kurten, and L.G. Johnson Attenuation of monocrotaline-induced pulmonary hypertension by luminal aav serotype 9 gene transfer of prostacyclin synthase Hum Gene Ther 25 2014 498 505
20. K. Takemiya, H. Kai, H. Yasukawa, N. Tahara, S. Kato, and T. Imaizumi Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats Basic Res Cardiol 105 2010 409 417
21. Y. Yamazato, A.J. Ferreira, K.H. Hong, S. Sriramula, J. Francis, M. Yamazato, and et al. Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer Hypertension 54 2009 365 371
22. H. Su, J. Arakawa-Hoyt, and Y.W. Kan Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model Proc Natl Acad Sci 99 2002 9480 9485
23. M. Yamakawa, L.X. Liu, T. Date, A.J. Belanger, K.A. Vincent, G.Y. Akita, and et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors Circ Res 93 2003 664 673
24. T. Khan, F. Sellke, and R. Laham Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia Gene Ther 10 2003 285 291
25. M.R. Hoenig, C. Bianchi, A. Rosenzweig, and F.W. Sellke Decreased vascular repair and neovascularization with ageing: mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1 Curr Mol Med 8 2008 754 767
26. N. Nagaya, K. Kangawa, M. Kanda, M. Uematsu, T. Horio, N. Fukuyama, and et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells Circulation 108 2003 889 895
27. H. Iwaguro, J.I. Yamaguchi, C. Kalka, S. Murasawa, H. Masuda, S.-I. Hayashi, and et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration Circulation 105 2002 732 738
28. Y.D. Zhao, D.W. Courtman, Y. Deng, L. Kugathasan, Q. Zhang, and D.J. Stewart Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease Circ Res 96 2005 442 450
29. Q. Zhao, Z. Liu, Z. Wang, C. Yang, J. Liu, and J. Lu Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension Ann Thorac Surg 84 2007 544 552
30. C. Liu, Z. Yan, C. Fang, G. Cao, B. Wang, S. Li, and et al. Establishment and comparison of two reliable hyperkinetic pulmonary hypertension models in rabbits J Thorac Cardiovasc Surg 148 2014 2353 2359
31. D.P. Griese, S. Achatz, C.A. Batzlsperger, U.G. Strauch, B. Grumbeck, J. Weil, and et al. Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells Cardiovasc Res 58 2003 469 477
32. J.M. Aliotta, P.J. Keaney, R.R. Warburton, M. DelTatto, M.S. Dooner, M.A. Passero, and et al. Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension Stem Cells Develop 18 2008 773 781
33. A.K. Alencar, S.L. Pereira, T.L. Montagnoli, R.C. Maia, A.E. Kümmerle, S.S. Landgraf, and et al. Beneficial effects of a novel agonist of the adenosine a2a receptor on monocrotaline-induced pulmonary hypertension in rats Br J Pharmacol 169 2013 953 962
34. A.L. George, P. Bangalore-Prakash, S. Rajoria, R. Suriano, A. Shanmugam, A. Mittelman, and et al. Endothelial progenitor cell biology in disease and tissue regeneration J Hematol Oncol 4 2011 24 31
35. L. Liu, Z.Z. Liu, H. Chen, G.J. Zhang, Y.H. Kong, and X.X. Kang Oxidized low-density lipoprotein and β-glycerophosphate synergistically induce endothelial progenitor cell ossification Acta Pharmacol Sinica 32 2011 1491 1497
36. P. Yuan, W.H. Wu, L. Gao, Z.Q. Zheng, D. Liu, H.Y. Mei, and et al. Oestradiol ameliorates monocrotaline pulmonary hypertension via no, prostacyclin and endothelin-1 pathways Eur Respir J 41 2013 1116 1125
37. M. Jiang, B. Wang, C. Wang, B. He, H. Fan, T.B. Guo, and et al. Angiogenesis by transplantation of hif-1 alpha modified epcs into ischemic limbs J Cell Biochem 103 2008 321 334
38. J. Hanze, N. Weissmann, F. Grimminger, W. Seeger, and F. Rose Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling Thromb Haemost 97 2007 774
39. G.L. Semenza Hif-1: mediator of physiological and pathophysiological responses to hypoxia J Appl Physiol 88 2000 1474 1480
40. J. Hu, D.J. Discher, N.H. Bishopric, and K.A. Webster Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand Biochem Biophys Res Commun 245 1998 894 899
41. C.S. Lim, S. Kiriakidis, A. Sandison, E.M. Paleolog, and A.H. Davies Hypoxia-inducible factor pathway and diseases of the vascular wall J Vasc Surg 58 2013 219 230